Stay updated on Finerenone and Empagliflozin Combination in CKD Clinical Trial

Sign up to get notified when there's something new on the Finerenone and Empagliflozin Combination in CKD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Finerenone and Empagliflozin Combination in CKD Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T06:17:07.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A new addition was made on January 22, 2025, following the deletion of content on January 15, 2025.
    Difference
    0.3%
    Check dated 2025-01-27T02:49:50.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The website has been updated to version 2.14.1 on January 15, 2025, following the removal of version 2.14.0 on December 19, 2024.
    Difference
    1%
    Check dated 2025-01-19T20:27:20.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    1.0%
    Check dated 2025-01-12T17:09:38.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    A new addition was made on December 19, 2024, while a deletion occurred on November 26, 2024.
    Difference
    0.6%
    Check dated 2024-12-21T23:05:59.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T22:31:00.000Z thumbnail image

Stay in the know with updates to Finerenone and Empagliflozin Combination in CKD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Finerenone and Empagliflozin Combination in CKD Clinical Trial page.